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PATENT PROTECTION FOR UNITED STATES
INVENTIONS IN THE PRINCIPAL
EUROPEAN COUNTRIES-
EXISTING SYSTEMS
S. DELVALLE GOLDSMITH *
THE PRESENT INDEPENDENT NATIONAL PATENT SYSTEMS
Notwithstanding theoretical discussion of supranational patent
systems for many decades and an actual draft of a supranational
European Patent Convention published in October 1962, the present
situation is basically still a regime of national patent systems, inde-
pendent and different. Consequently, the American inventor or as-
signee is faced with the necessity of obtaining at least thirteen separate
patents (the six Common Market Countries plus the "Outer Seven")
to obtain complete European patent protection—quite apart from
the Soviet Union and its satellites.
Despite the thirteen or more different patents, some grouping
may be effected on the basis of the general nature of the patent sys-
tems involved, the type and nature of the patents, the protection af-
forded, and the enforcement means. The main groupings are as follows:
1—The examining countries;
2—The non-examining countries;
3—The Soviet and satellite countries.
The first category can be subdivided into the British-practice
countries and the German-practice countries. In Europe only Great
Britain and Ireland fall into the first category, but the basic British
practice has been carried over to the Dominions and former Dominions
such as Australia, New Zealand, South Africa (to a certain extent),
India and Pakistan as well as present and former British colonies.
(Canada must be considered in a class by itself—including features
of both the United States and British practices.)
The German-practice is exemplified by West Germany itself,
Austria, Holland, Sweden, Norway and Denmark. Holland has just
commenced operating under a drastically changed law which will be
referred to at a later point.
The non-examination practice is exemplified by France, Belgium,
Italy and Luxembourg. In France, however, there has been some
breaking away from a pure non-examination system: "Special Medica-
ment Patents" (BSM) are subjected to a novelty examination, and a
law is on the books—but not yet in effect—for novelty examination
of other patents as well.
*.Member of the New York Bar.
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The U.S.S.R. and satellite countries are in a world of'their own as
far as patents are concerned. They have apparently felt it necessary
to take over the bare bones of a capitalistic patent system but, apart
from regular patents which are granted chiefly to foreigners, inventions
are generally rewarded by "Certificates of Authorship." These involve
giving the invention to the government and receiving an ex gratia
award rather than a commercially usable patent. Practically all inven-
tions made by nationals are in the form of applications for Authorship
Certificates. In view of the general nature of the Soviet economy,
inventions can, of course, only be exploited through a government
agency, .so that even the grant of a regular patent merely affords an
opportunity to deal with the government. As the Soviet system is so
different from the others and as so little use of it is made by American
inventors, it will not be further discussed here.
Coming back to the countries outside the Iron Curtain, both the
examination and non-examination countries have in common (and in
common with the United States patent system) the requirement of
filing a description of the invention and, in most cases, claims pointing
out what is considered to be the patentable novelty of the invention.
In France, instead of claims, a so-called Resume is used which,
although listing the features of the invention, is not determinative of
the scope of the patent. While claims are generally used in Belgium,
Italy and Luxembourg, they do not have the significance of United
States claims and recourse is had to the description of the invention in
relation to the prior art to determine the inventive contribution.
In the examination countries, on the other hand, claims are im-
portant—but with their effect varying from country to country. Thus,
in Great Britain, courts restrict the patentee to what he has claimed,
subject both to interpretation of the claims in the light of the specifica-
tion and to application of the "doctrine of equivalents" to an extent
depending on the nature of the invention. In Germany, however, the
courts will often give a patentee a greater or different protection than
indicated by the wording of his claims.
As to the examination itself, here again there is a gradation from
the strict and comprehensive investigations of Germany, Holland and
the Scandinavian countries to the British examination, which chiefly
considers earlier British patents. Moreover, the German examination
takes into account questions of so-called "inventive height" and
patents are refused for novel inventions that are considered not to
achieve an advance in the art or that would be obvious to the skilled
workman in the art. Conversely, in England, the Patent Office Exam-
iner may not refuse a patent for an invention which is novel.
At this point attention must be directed to the "opposition" prac-
tice of the examination countries. This provides an opportunity for
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interested third parties to raise objection to a patent after it has been
allowed by the Examiner and published, but before it is granted. In
the German-practice countries, opposition provides in effect a second
(and usually more rigorous) examination on an inter partes basis. In
Great Britain the opposition procedure goes much farther than the
regular examination, since prior art of all kinds (and even prior use)
may be cited and quantum of invention considered. In Germany the
practice has grown up over the years of a close scrutiny of com-
petitors' activities, as shown by published patent applications, and in
important cases it is not unusual for a number of oppositions to be
filed against a single application. In Germany, Holland and Great
Britain patent applications are printed on allowance (i.e., before grant)
which facilitates their review for opposition purposes.
As a result of examination and opposition in the examining coun-
tries, a finally granted patent has a considerable aura of validity and
respectability—even though in the last analysis validity must be deter-
mined by the courts. In countries such as France, however, a patent
has no such presumption of validity, as emphasized by the legend
"S.G.D.G." (Sans Garantie du Gouvernment) which appears on every
French patent. Yet, if there is a corresponding German or Dutch
patent, a good idea of the scope of a French patent can be obtained
from the claims of these other patents.
An important difference of most foreign patent laws from the
United States law is that the foreign laws generally require "working"
of an invention (i.e., manufacture in the country) within a fixed term
after grant. In many countries, originally, the penalty for non-working
was revocation of the patent, but this has generally been ameliorated to
provide instead for "compulsory licensing." This means that, if an
invention is not worked, an interested party has the possibility of
obtaining a license even without the patentee's consent, although with
payment of a royalty to him.
The history of compulsory licensing shows very few applications
for license, which has given the impression that this system does not
represent a weakening of patent protection. Consequently, even in the
United States, there have been proponents of compulsory licensing.
The lack of applications for compulsory licenses does not mean, how-
ever, that the system has no effect, but rather that the prospective
licensee and patentee usually try to reach an agreement directly rather
than through official channels, with the patentee of course realizing
that compulsory licensing is available if agreement is not reached.
As a result, any provision in the patent law of a country (or in
a supranational patent law) for compulsory licensing means reducing
the strength and value of the patent right. If in the United States we
still wish to give inventors for limited times the exclusive right to their
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discoveries (as provided in the Constitution), any proposals for in-
cluding compulsory licensing in any part of the United States patent
laws should receive most careful study before enactment.
THE PRESENT INTERNATIONAL REGIME OF THE PARIS CONVENTION
In addition to the separate or national patent systems referred
to above, there is an existing international—although not supranational
—patent system. That system is the one formulated at the so-called
International or Paris Convention of 1883 as modified by various
subsequent amendments, including the most recent one of Lisbon in
1958. This patent and trademark Convention of about sixty countries,
while not providing for a single patent or single trademark registration,
furnishes not only certain minimums of protection and treatment in
each country, but also priority periods which facilitate filing by na-
tionals of one country in the other countries of the group. All the
European countries except the U.S.S.R. are members of this Convention.
The most important provision of the Paris Convention from the
viewpoint of patent filing is the one-year term, commencing on the date
of the first application for patent protection in a Convention country,
for filing applications in the other Convention countries with the benefit
of the original filing date. This means that the inventor does not have
to go to the trouble and expense of filing in other countries simulta-
neously with, or shortly after, filing in his home country in order to
escape bars of publication or use. He can wait (up to one year) until
he has more information as to the value of his invention and possibly
the result of examination in his home country—although the latter is
not so likely with the present backlogs in patent offices throughout the
world. When he does file in the other countries within the "Convention
year," his patent cannot be anticipated by interim publication use or
even by an interim similar application of a third party.
The next advantage of the Paris Convention, and perhaps the
most important one from a juridical viewpoint, is its guaranty of
"national treatment." This means that the national of one Convention
country applying for or owning a patent or trademark in a second
Convention country must receive the same treatment and the same
protection as a national of the second country, particularly with respect
to the legal remedies for violation of his rights. He cannot be made to
pay higher fees or taxes, or comply with more stringent requirements,
than the nationals of the second country. In the direction of estab-
lishing minimums of protection, the Convention requires all member
countries to provide protection for various types of invention, to
provide reasonable periods for the payment of taxes, and to ensure
that patents will not be revoked for "non-working" (i.e., failure to
exploit the invention within the country) except where compulsory
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licensing will not prevent abuse of the patent monopoly.
The American inventor desiring to secure foreign protection for
his invention should take advantage of Convention priority whenever
possible inasmuch as the antedating of his patent by as much as
twelve months may mean the difference between a valid and an invalid
grant. It should be borne in mind that this antedating applies only
to the Convention countries, and that in other countries it may be
necessary to file shortly after the United States filing date to avoid
bars of prior publication and use. Moreover, in the Convention coun-
tries, even if foreign filing is effected within the year allowed, this
does not remove the effect of any publication or use of the invention
before The United States filing date. Therefore, such publication or
use must be prevented, when foreign filing is in prospect, even though
it may not harm the United States patent due to the provision in this
country of a "free period" of one year during which a United States
patent application may be filed after publication or use of the inven-
tion. In the European countries there is generally no corresponding
"free period" except in West Germany where there is a "free period"
of six months. This runs back from the actual German filing date and
not from the filing date of the basic Convention application. Conse-
quently, if the German application is filed with Convention priority
six months or more after the United States application, the "free
period" has no additional effect.
One ameliorating circumstance in some of the European countries
is that prior publication or use must be domestic, i.e., within the
country, to be a bar. This applies to both publication and use in Great
Britain and Ireland, and to use in Belgium, Germany and Austria. On
the other hand, in Italy, France, Holland and Sweden, publication or
use anywhere is a bar. Consequently, in the latter countries, publica-
tion or use (sufficient to divulge the invention) would destroy the
validity of a Convention case if before the basic filing date, or if a
non-Convention case, before the respective foreign filing date.
SPECIAL PROBLEMS IN CONNECTION WITH CHEMICAL AND
PHARMACEUTICAL INVENTIONS
Whereas the American inventor of a mechanical or electrical
invention can expect the same general treatment in the foreign countries
as in the United States, this is not the case for chemical and pharma-
ceutical inventions. Protection for these types of inventions is often
restricted abroad and obtaining the best protection available usually
requires special treatment of the description and claims.
Thus, a United States patent for a new chemical or pharmaceutical
invention provides product protection independent of the process used
to make the product, and the specification can be drafted from the
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standpoint of the product and with little regard for the process or
processes by which it is prepared. Under the German and other similar
laws, however, independent product protection for a chemical, pharma-
ceutical or food invention is not obtainable and such inventions must
be claimed in terms of a process for preparing the product. A patent
application in these countries should therefore claim the process as
broadly as possible and the description must provide a proper basis
for such breadth of claim.
The problem of getting adequate protection for an invention of
this type abroad is not quite so difficult as it might appear for two
reasons. In the first place, a process claim generally affords protection
for the product of the process—even if the process is carried out
abroad and the product imported. In the second place, a claim will
usually be granted for a so-called "analogy process." This is a process
of known type, e.g., a standard chemical reaction, but applied to differ-
ent starting materials to produce a new product. Patentability is
imparted to the invention by unexpected characteristics of the final
product rather than by the inventiveness of the process.
In order to support a broad process claim, either of the "inventive
process" or "analogy process" type, the specification should describe
various methods of preparing the products of the invention
—not just
the one process which is often all that is described in the United States
case where product claims are relied upon for protection. In addition to
a general reference to various possible processes, a number of specific
examples are advantageous both for the purpose of exemplifying the
different processes and also to pin-point preferred final products and
final products characteristic of the range or breadth of the claims.
Nevertheless, a multiplicity of examples, or long lists of compounds,
which do not give physical and chemical properties of the final products
will not be of much value.
Although in the German-practice countries independent product
protection cannot be obtained for individual chemical compounds, such
claims can be obtained for compositions or mixtures except in the
pharmaceutical and food fields. Therefore, composition claims—assum-
ing a synergistic or non-additive effect of the ingredients of the com-
position—provide another approach to patent protection. In addition,
"use" claims and special forms of process claims can be obtained in
some of the countries.
Independent product protection for chemical compounds and
pharmaceuticals is obtainable in Great Britain, France (through the
special BSM patents for pharmaceuticals), and Belgium. In Italy,
independent product protection is obtainable for chemicals but no
protection (product or process) is obtainable for medicines. This
presents the rather anomalous situation that Italians can obtain patents
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elsewhere in the world for their pharmaceutical inventions but no one
can obtain pharmaceutical patent protection in Italy.
INTERNATIONAL PROPOSALS
Proposals for a world or regional patent have been made from
almost the earliest times of national patent systems. Up to quite
recently, nothing has come of these proposals—even in the British
Empire during its most closely-knit period. However, under the impetus
of the European Economic Community (Common Market), serious
efforts have been made over the past several years to lay the founda-
tion for a common patent. These efforts culminated in the publication
in October 1962, of a draft European Patent Convention by the so-
called Haertel Committee. This committee was charged with that task
by a coordinating Committee for Industrial Property set up by the
Common Market Commission.
As will be apparent from the preceding discussion of the diverse
national patent systems, the task of drafting a common patent law
was not an easy one. The ideas of the different European countries
as to examination, protected subject matter, significance of claims,
patent terms, and methods of enforcement vary greatly, and the need
for compromise to devise a system that might be acceptable to the
various countries was apparent. Moreover, an even greater difference
of opinion developed on certain items which were not taken from any
of the national patent systems but arose from the very nature of a
supranational patent right, principally the question of "accessibility"
which has been a real stumbling block to agreement. This has to do
with whether a non-member national, e.g., an American, would be
able to obtain a European patent. Arguments and feeling have run very
hot both on the basis of whether outsiders should have the privileges
of the members of the "club" and whether the number of applications
from outsiders would be so great that the proposed European Patent
Office would be swamped to the extent of not being able to operate
at all. This question is by no means settled yet, but the majority view
at the moment seems to be against accessibility, notwithstanding argu-
ments that accessibility is required under the "national treatment"
clause of the Paris Convention.
In addition to the proposals of the Haertel Committee for a
supranational patent, work has been progressing for a number of
years by an Experts Committee of the Council of Europe towards the
harmonizing of the separate national patent laws. The Council con-
sists of sixteen European countries, including the six Common Market
countries. Two Conventions (relating to classification and formalities)
are already in effect among some of these countries, and a harmoniza-
tion Convention has already been completed and signed by ten coun-
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tries. Although, up to now, these harmonization proposals have taken
somewhat of a back seat in view of the more dramatic nature of the
proposed Common Market Patent, to the extent that the latter has
run into delays and difficulties, the more are the Council's harmoniza-
tion proposals coming to the foreground as a really practical way of
facilitating international patent protection. These and other current
international proposals will be dealt with in a separate article in this
symposium.
Although not an international proposal, mention should be made,
in this connection, of the new Dutch patent law which has already been
referred to briefly above. It has some of the ideas of the European
Patent Convention, particularly as to the provision of a system of
deferred examination. The purpose of this provision is primarily to
avoid unnecessary examination of patents which may be dropped or
abandoned within the first few years of their existence.
It is interesting that Holland, which has been one of the most
precise examining countries, should go over to a system which will
mean no examination at all in many cases. Under the Dutch law,
which came into effect January 1, 1964, examination must be
requested within seven years of filing or the patent will lapse. It is
also interesting that, notwithstanding the efforts toward a common
European patent, the Dutch have decided to effect drastic revision of
their law. This would seem to indicate that a European patent is not
"around the corner."
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